Open AccessFasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)
Author(s) -
Ele Ferrannini,
Simona Baldi,
Tiziana Scozzaro,
Vasilis Tsimihodimos,
Fisseha Tesfaye,
Wayne Shaw,
Norman Rosenthal,
Gemma A. Figtree,
Bruce Neal,
Kenneth W. Mahaffey,
Vlado Perkovic,
Michael K. Hansen
Publication year - 2022
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc21-2398
Subject(s) - medicine , canagliflozin , diabetes mellitus , endocrinology , cardiology , type 2 diabetes
To examine whether the circulating substrate mix may be related to the incidence of heart failure (HF) and cardiovascular (CV) mortality and how it is altered by canagliflozin treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom